Srinagar, Jul 22 (UNI) Asserting that the antiviral drug Remdesivir reduces the risk of death among Covid-19 patients, Doctors Association Kashmir (DAK) on Wednesday said the drug is unaffordable for poor patients.
'Because of high cost, Remdesivir is out of reach for poor people,' DAK president and influenza expert Dr Nisar ul Hassan said.